During the past decade, GNP Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "GNP Research" are "Diffuse Cutaneous Systemic Sclerosis" (1 trials), "Pulmonary Disease, Chronic Obstructive" (1 trials), "Respiration Disorders" (1 trials) and "Sleep Apnea, Obstructive" (1 trials). Many other conditions were trialed in "GNP Research" in a lesser frequency.

Most popular intervention types in "GNP Research" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Lemborexant 10 mg" (1 trials) and "MT-7117" (1 trials). Other intervention names were less common.

The vast majority of trials in "GNP Research" are 2 trials for "All" genders.

Currently, there are NaN active trials in "GNP Research". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in GNP Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in GNP Research, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".